Russell Investments Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191K Buy
5,567
+4,716
+554% +$139K ﹤0.01% 3193
2026
Q1
$26.3K Sell
851
-78
-8% -$1.92K ﹤0.01% 3538
2025
Q4
$19.4K Buy
929
+19
+2% +$353 ﹤0.01% 3635
2025
Q3
$14.3K Buy
+910
New +$18.8K ﹤0.01% 3702
2022
Q1
Sell
-2,810
Closed -$129K 2958
2021
Q4
$129K Sell
2,810
-946
-25% -$54.3K ﹤0.01% 2802
2021
Q3
$251K Sell
3,756
-34
-0.9% -$2.79K ﹤0.01% 2703
2021
Q2
$403K Sell
3,790
-354
-9% -$42K ﹤0.01% 2680
2021
Q1
$630K Buy
4,144
+3,911
+1,679% +$636K ﹤0.01% 2430
2020
Q4
$39K Buy
+233
New +$41.4K ﹤0.01% 2944

Other funds holding TECX

Russell Investments Group's TECX Position: Q2 2026 in Review

Russell Investments Group increased its Tectonic Therapeutic (TECX) stake by 554% in Q2 2026, buying an estimated $139K and bringing the position to 5,567 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Russell Investments Group first reported a position in TECX in Q4 2020 and has held it in 9 quarters since. The position peaked at $630K in Q1 2021. 42 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Russell Investments Group held 5,567 shares of Tectonic Therapeutic worth $191K as of Q2 2026.
  • Russell Investments Group bought 4,716 Tectonic Therapeutic shares in Q2 2026, an estimated $139K.
  • Tectonic Therapeutic made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3193 holding.
  • Russell Investments Group first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 9 quarters since.
  • Russell Investments Group's Tectonic Therapeutic position peaked at $630K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.